• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Glenmark gets final US FDA nod for generic Cutivate lotion

      Posted Atmoneycontrol.com

      Glenmark Generics Inc, the US arm of India’s Glenmark Pharmaceuticals, has received final approval from US Foods and Drugs Administration for its Abbreviated New Drug Application (ANDA) for Fluticasone Propionate skin lotion.

      Glenmark’s Fluticasone Propionate is the generic version of US pharmaceutical company Nycomed’s Cutivate lotion.

      Nycomed had in 2008 filed a patent infringement lawsuit in relation to Glenmark’s ANDA for fluticasone propionate lotion. Glenmark filed a paragraph IV certification that involves a patent challenge with the US drug regulator for its generic version.

      Glenmark said if it wins the patent challenge it will be able to market drug exclusively for 180 days.

      Nycomed’s Cutivate lotion had sales of about USD 48 million in 2010 in the US market.

      Glenmark shares opened 2% higher on the announcement, and were trading up 1% at Rs 301 in early trade on National Stock Exchange.

      May 04, 2011


      Share this Article!

    Back to top^